Cinqair is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Cinqair is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameCinqair
Authorized genericreslizumab
Regular genericreslizumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Cinqair?
The original
–
–

Brand nameThe maker’s card

CINQAIR Cost Support Program (Copay Card)

Savings card from Teva Respiratory

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on cinqair.com 

Or call 1-844-838-2211.

In the maker’s words

“If you have commercial health insurance coverage for CINQAIR, you may pay as little as $0 out-of-pocket for the cost of CINQAIR and its administration.”

From the maker’s offer on cinqair.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Cinqair itself, from the same company, sold without the brand name, and usually for less. For now Cinqair is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Cinqair is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

CINQAIR is an interleukin-5 antagonist monoclonal antibody (IgG4 kappa) indicated for add-on maintenance treatment of patients with severe asthma aged 18 years and older, and with an eosinophilic phenotype.

Limitations of Use: CINQAIR is not indicated for:

  • treatment of other eosinophilic conditions
  • relief of acute bronchospasm or status asthmaticus

Source: the FDA label for Cinqair (Teva Respiratory, LLC), February 29, 2020. Full label on DailyMed 

Good to know